Daily as of 3 Nov 16:00 ET
- Price
- above both $17.82 vs 50 $17.58 / 200 $15.37
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 26 Aug 2026 · projected 28 bars out
JANX | Janux TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$17.82
+$0.36 (+2.06%)
Janux Therapeutics (JANX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $17.47 vs 50 $15.82 / 200 $24.69
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 2 Feb 2026 · projected 10 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $17.82 vs 50 $17.32 / 200 $16.65
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 25 Jun 2026 · projected 4 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Aug 2026 | 🟨Golden steep | daily | 28 bars out | Not tested |
| 25 Jun 2026 | 🟨Golden | 4-hour | 4 bars out | Not tested |
| 12 Jun 2026 | 💀Death | 4-hour | 19 bars out | 2 bar cross test |
| 24 Apr 2026 | 🟨Golden | 4-hour | 22 bars out | 2 bar cross test |
| week of 2 Feb 2026 | 💀Death steep | weekly | 10 bars out | Not tested |
About JANX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall